Abstract 5231: NK and T cells armed with EVE16, a novel synthetic immune receptor, mediate robust anti-tumor responses through dual direct cytotoxicity and ADCC with minimal trogocytosis and exhaustion

Authors: Alaa Ali, James D. Ham, Faten Zairi, Vaishvi Patel, Mubin Tarannum, Khanhlinh Dinh, Yasmin Abdulhamid, Juliana Vergara, Robert Soiffer, Jerome Ritz, John Beadle, Nikola A. Ivica, Jianzhu Chen, Rizwan Romee

Published: 2024-03-22

DOI: 10.1158/1538-7445.am2024-5231

Source: Full article